Medicine

J. Heier, David M. Brown, V. Chong, J. Korobelnik, P. Kaiser, Q. Nguyen, B. Kirchhof, A. Ho, Y. Ogura, G. Yancopoulos, N. Stahl, R. Vitti, Alyson J. Berliner, Y. Soo, Majid Anderesi, G. Groetzbach, B. Sommerauer, R. Sandbrink, C. Simader, U. Schmidt-Erfurth

2012.12.1OPHTHALMOLOGY

DOI: 10.1016/j.ophtha.2012.09.006

tlooto Summary

It is demonstrated that aflibercept is an effective treatment for AMD, with the every-2-month regimen offering the potential to reduce the risk from monthly intravitreal injections and the burden of monthly monitoring.

Abstract

Abstract is not available.

Citation format

HEIER, J., et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. OPHTHALMOLOGY, 2012, 119 12: 2537–48.